Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
36.91
+0.30 (0.82%)
Jun 5, 2025, 4:00 PM - Market closed

Ultragenyx Pharmaceutical Stock Forecast

Stock Price Forecast

According to 17 professional analysts, the 12-month price target for Ultragenyx Pharmaceutical stock ranges from a low of $48 to a high of $140. The average analyst price target of $92.29 forecasts a 150.04% increase in the stock price over the next year.

Price Target: $92.29 (+150.04%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $48 $92.29 $81 $140
Change +30.05% +150.04% +119.45% +279.30%

Analyst Ratings

The average analyst rating for Ultragenyx Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 666666
Buy 7888810
Hold 111111
Sell 000000
Strong Sell 000000
Total 141515151517

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
William Blair
William Blair
Buy
Initiates
$65
Buy Initiates $65 +76.10% May 28, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$64$65
Buy Maintains $64$65 +76.10% May 9, 2025
JP Morgan
JP Morgan
Buy
Maintains
$104$117
Buy Maintains $104$117 +216.99% Mar 27, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$140$115
Buy Maintains $140$115 +211.57% Mar 17, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$118
Buy Reiterates $118 +219.70% Feb 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
666.34M
from 560.23M
Increased by 18.94%
Revenue Next Year
859.12M
from 666.34M
Increased by 28.93%
EPS This Year
-5.35
from -6.29
EPS Next Year
-3.71
from -5.35
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
271.03M351.41M363.33M434.25M560.23M666.34M859.12M1.26B
Revenue Growth
161.32%29.66%3.39%19.52%29.01%18.94%28.93%46.78%
EPS
-3.07-6.70-10.12-8.25-6.29-5.35-3.71-1.29
EPS Growth
--------
Forward PE
--------
No. Analysts
-----222116
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 702.8M 1.1B 1.8B
Avg 666.3M 859.1M 1.3B
Low 620.0M 684.5M 783.9M

Revenue Growth

Revenue Growth 20252026202720282029
High
25.5%
60.4%
110.4%
Avg
18.9%
28.9%
46.8%
Low
10.7%
2.7%
-8.8%

EPS Forecast

EPS 20252026202720282029
High -4.59 -0.86 1.09
Avg -5.35 -3.71 -1.29
Low -6.89 -5.27 -3.73

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.